Latest Amplimmune Inc. Stories

2014-05-07 12:29:28

Amplimmune, Inc. and Medimmune are honored as the best deals in Mergers and Acquisitions and Isis Pharmaceuticals and Biogen Idec for Biopharmaceutical Licensing PHILADELPHIA, May 7, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, honored Amplimmune, Inc. and Medimmune for their work in pharmaceutical Mergers and Acquisitions (M&A), and Isis...

2010-08-04 09:08:00

ROCKVILLE, Md., Aug. 4 /PRNewswire/ -- Amplimmune, Inc. today announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases. GSK will obtain exclusive worldwide rights to AMP-224 as well as other potential next generation fusion proteins that target PD-1. Under the terms of this agreement, GSK will pay Amplimmune a non-refundable upfront payment of...

Word of the Day
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.